{"id":"https://openalex.org/W15900271","doi":"https://doi.org/10.1089/cbr.2013.1570","title":"Gallium-68 DOTATOC PET/CT In Vivo Characterization of Somatostatin Receptor Expression in the Prostate","display_name":"Gallium-68 DOTATOC PET/CT In Vivo Characterization of Somatostatin Receptor Expression in the Prostate","publication_year":2014,"publication_date":"2014-01-22","ids":{"openalex":"https://openalex.org/W15900271","doi":"https://doi.org/10.1089/cbr.2013.1570","mag":"15900271","pmid":"https://pubmed.ncbi.nlm.nih.gov/24450327","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3961796"},"language":"en","primary_location":{"id":"doi:10.1089/cbr.2013.1570","doi":"https://doi.org/10.1089/cbr.2013.1570","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cbr.2013.1570","pdf_url":null,"source":{"id":"https://openalex.org/S87235987","display_name":"Cancer Biotherapy and Radiopharmaceuticals","issn_l":"1084-9785","issn":["1084-9785","1557-8852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biotherapy and Radiopharmaceuticals","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3961796","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026977150","display_name":"Mila V Todorovi\u0107-Tirnani\u0107","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4068193","display_name":"University of Belgrade","ror":"https://ror.org/02qsmb048","country_code":"RS","type":"education","lineage":["https://openalex.org/I4068193"]},{"id":"https://openalex.org/I4210113171","display_name":"Univerzitetski Klini\u010dki Centar Srbije","ror":"https://ror.org/02122at02","country_code":"RS","type":"healthcare","lineage":["https://openalex.org/I4210113171"]}],"countries":["RS"],"is_corresponding":true,"raw_author_name":"Mila V. Todorovi\u0107-Tirnani\u0107","raw_affiliation_strings":["Center for Nuclear Medicine, Clinical Center of Serbia, Serbia","Faculty of Medicine, University of Belgrade, Serbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Nuclear Medicine, Clinical Center of Serbia, Serbia","institution_ids":["https://openalex.org/I4210113171"]},{"raw_affiliation_string":"Faculty of Medicine, University of Belgrade, Serbia","institution_ids":["https://openalex.org/I4068193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089298304","display_name":"Milan M. Gaji\u0107","orcid":"https://orcid.org/0009-0003-2647-5549","observed_orcids":["https://orcid.org/0009-0003-2647-5549"]},"institutions":[{"id":"https://openalex.org/I4068193","display_name":"University of Belgrade","ror":"https://ror.org/02qsmb048","country_code":"RS","type":"education","lineage":["https://openalex.org/I4068193"]}],"countries":["RS"],"is_corresponding":false,"raw_author_name":"Milan M. Gaji\u0107","raw_affiliation_strings":["Institute for Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, Serbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, Serbia","institution_ids":["https://openalex.org/I4068193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103358287","display_name":"Vladimir B. Obradovi\u0107","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4068193","display_name":"University of Belgrade","ror":"https://ror.org/02qsmb048","country_code":"RS","type":"education","lineage":["https://openalex.org/I4068193"]},{"id":"https://openalex.org/I4210113171","display_name":"Univerzitetski Klini\u010dki Centar Srbije","ror":"https://ror.org/02122at02","country_code":"RS","type":"healthcare","lineage":["https://openalex.org/I4210113171"]}],"countries":["RS"],"is_corresponding":false,"raw_author_name":"Vladimir B. Obradovi\u0107","raw_affiliation_strings":["Center for Nuclear Medicine, Clinical Center of Serbia, Serbia","Faculty of Medicine, University of Belgrade, Serbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Nuclear Medicine, Clinical Center of Serbia, Serbia","institution_ids":["https://openalex.org/I4210113171"]},{"raw_affiliation_string":"Faculty of Medicine, University of Belgrade, Serbia","institution_ids":["https://openalex.org/I4068193"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051446048","display_name":"Richard Paul Baum","orcid":"https://orcid.org/0000-0003-1723-0075","observed_orcids":["https://orcid.org/0000-0003-1723-0075"]},"institutions":[{"id":"https://openalex.org/I4210107095","display_name":"Zentralklinik Bad Berka","ror":"https://ror.org/00zfe1b87","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210107095"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Richard P. Baum","raw_affiliation_strings":["Department of Nuclear Medicine, Centre for PET/CT, Bad Berka, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Centre for PET/CT, Bad Berka, Germany","institution_ids":["https://openalex.org/I4210107095"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5026977150"],"corresponding_institution_ids":["https://openalex.org/I4068193","https://openalex.org/I4210113171"],"apc_list":null,"apc_paid":null,"fwci":0.9829,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.74646575,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"29","issue":"3","first_page":"108","last_page":"115"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9042999744415283,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9042999744415283,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.05209999904036522,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":0.008299999870359898,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/somatostatin-receptors","display_name":"somatostatin receptors","score":0.7829999923706055},{"id":"https://openalex.org/keywords/68ga-dotatoc","display_name":"68Ga-DOTATOC","score":0.8899999856948853},{"id":"https://openalex.org/keywords/prostate","display_name":"prostate","score":0.8529999852180481},{"id":"https://openalex.org/keywords/neuroendocrine-tumors","display_name":"neuroendocrine tumors","score":0.6800000071525574},{"id":"https://openalex.org/keywords/suvmax","display_name":"SUVmax","score":0.6700000166893005},{"id":"https://openalex.org/keywords/prostatic-hyperplasia","display_name":"prostatic hyperplasia","score":0.972000002861023},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.878000020980835},{"id":"https://openalex.org/keywords/reference-values","display_name":"reference values","score":0.5860000252723694},{"id":"https://openalex.org/keywords/patient-age","display_name":"patient age","score":0.5360000133514404}],"concepts":[{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.8216053247451782},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7762377262115479},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7120971083641052},{"id":"https://openalex.org/C2777562237","wikidata":"https://www.wikidata.org/wiki/Q835051","display_name":"Hyperplasia","level":2,"score":0.6800744533538818},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.532175600528717},{"id":"https://openalex.org/C80115893","wikidata":"https://www.wikidata.org/wiki/Q2067077","display_name":"Somatostatin receptor","level":3,"score":0.4930090606212616},{"id":"https://openalex.org/C87874733","wikidata":"https://www.wikidata.org/wiki/Q18039844","display_name":"PCA3","level":4,"score":0.48226219415664673},{"id":"https://openalex.org/C199374082","wikidata":"https://www.wikidata.org/wiki/Q907080","display_name":"Standardized uptake value","level":3,"score":0.4756624102592468},{"id":"https://openalex.org/C167414201","wikidata":"https://www.wikidata.org/wiki/Q1955391","display_name":"Muscle hypertrophy","level":2,"score":0.41499215364456177},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.39656397700309753},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36685219407081604},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33625274896621704},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32817190885543823},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.23800337314605713},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.21335089206695557},{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.12991702556610107}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005710","descriptor_name":"Gallium Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009942","descriptor_name":"Organometallic Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011467","descriptor_name":"Prostate","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D011467","descriptor_name":"Prostate","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011470","descriptor_name":"Prostatic Hyperplasia","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D014057","descriptor_name":"Tomography, X-Ray Computed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015282","descriptor_name":"Octreotide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D017481","descriptor_name":"Receptors, Somatostatin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D018358","descriptor_name":"Neuroendocrine Tumors","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D049268","descriptor_name":"Positron-Emission Tomography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1089/cbr.2013.1570","doi":"https://doi.org/10.1089/cbr.2013.1570","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cbr.2013.1570","pdf_url":null,"source":{"id":"https://openalex.org/S87235987","display_name":"Cancer Biotherapy and Radiopharmaceuticals","issn_l":"1084-9785","issn":["1084-9785","1557-8852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biotherapy and Radiopharmaceuticals","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3339923","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3961796","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:24450327","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24450327","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer biotherapy & radiopharmaceuticals","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3961796","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3961796/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biother Radiopharm","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:3339923","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3961796","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G6977937296","display_name":null,"funder_award_id":"175018","funder_id":"https://openalex.org/F4320322729","funder_display_name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja"}],"funders":[{"id":"https://openalex.org/F4320322679","display_name":"International Atomic Energy Agency","ror":"https://ror.org/02zt1gg83"},{"id":"https://openalex.org/F4320322729","display_name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","ror":"https://ror.org/01znas443"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W369028299","https://openalex.org/W1203287330","https://openalex.org/W1499584739","https://openalex.org/W1503754384","https://openalex.org/W1587021131","https://openalex.org/W1963940642","https://openalex.org/W1975281597","https://openalex.org/W1975450774","https://openalex.org/W1986723218","https://openalex.org/W2001213717","https://openalex.org/W2038858812","https://openalex.org/W2043448289","https://openalex.org/W2045681528","https://openalex.org/W2053194675","https://openalex.org/W2057382473","https://openalex.org/W2065361341","https://openalex.org/W2069832552","https://openalex.org/W2080916065","https://openalex.org/W2083348695","https://openalex.org/W2100737164","https://openalex.org/W2106067878","https://openalex.org/W2106680642","https://openalex.org/W2108035027","https://openalex.org/W2116290973","https://openalex.org/W2122280524","https://openalex.org/W2122334532","https://openalex.org/W2128006663","https://openalex.org/W2136711352","https://openalex.org/W2148239074","https://openalex.org/W2165708640","https://openalex.org/W2237644705","https://openalex.org/W2260953792","https://openalex.org/W2315339886","https://openalex.org/W2399736156","https://openalex.org/W2686809962","https://openalex.org/W4242739891","https://openalex.org/W4243066396","https://openalex.org/W4247442754","https://openalex.org/W4292291331"],"related_works":["https://openalex.org/W2228629344","https://openalex.org/W49266373","https://openalex.org/W1975450774","https://openalex.org/W4285554825","https://openalex.org/W2954552393","https://openalex.org/W600224310","https://openalex.org/W4390604298","https://openalex.org/W1970027158","https://openalex.org/W3181407106","https://openalex.org/W2963983295"],"abstract_inverted_index":{"AIM:":[0],"The":[1,61,123],"aim":[2],"was":[3,65,69,139,166,208],"to":[4],"investigate":[5],"somatostatin":[6],"receptor":[7],"(sstr)":[8],"expression":[9,132,146,156,165],"in":[10,24,147,154,168,183,192,199,213],"normal":[11,53,83,109,124,134,173],"prostate":[12,34,51,62,84,90,104,125,184,206],"by":[13,187],"determining":[14],"the":[15,33,38,50,179,193],"maximum":[16],"standardized":[17],"uptake":[18,182],"value":[19],"(SUVmax)":[20],"of":[21,32,49],"(68)Ga-DOTATOC":[22,46,77,176],"PET/CT":[23,177],"neuroendocrine":[25],"tumor":[26],"(NET)":[27],"patients,":[28],"without":[29],"NET":[30,43,188],"involvement":[31],"gland,":[35,52],"for":[36],"establishing":[37],"reference":[39],"standard.":[40],"METHODS:":[41],"Sixty-four":[42],"patients":[44],"underwent":[45],"PET/CT.":[47],"SUVmax":[48,78,212],"liver,":[54],"testes,":[55],"and":[56,118,144,160,202],"gluteus":[57,119],"muscles":[58],"were":[59,80,197],"evaluated.":[60],"gland":[63,126],"size":[64],"measured.":[66],"Statistical":[67],"analysis":[68],"performed":[70],"using":[71],"dedicated":[72],"software":[73],"(SPSS13).":[74],"RESULTS:":[75],"Mean/median":[76],"values":[79,196],"as":[81],"follows:":[82],"2.6":[85],"\u00b1":[86,92,97,102,107,112,116,121],"0.0,":[87],"slightly":[88],"enlarged":[89],"4.2":[91],"1.6,":[93,98],"prostatic":[94,99,158,169,200],"hypertrophy":[95,159],"4.9":[96],"hyperplasia":[100,201],"5.0":[101],"1.5,":[103],"cancer":[105,170,207],"9.5":[106],"2.1,":[108],"liver":[110,135],"7.3":[111],"1.8,":[113],"testes":[114],"1.8":[115],"0.5,":[117],"1.0":[120],"0.2.":[122],"had":[127],"three":[128],"times":[129],"less":[130],"sstr":[131,145,155,164,181],"than":[133,191],"tissue.":[136],"Strong":[137],"correlation":[138],"found":[140,167],"between":[141,157],"patient":[142],"age":[143],"prostate/prostate":[148],"size.":[149],"No":[150],"significant":[151],"difference":[152],"existed":[153],"hyperplasia.":[161],"Much":[162],"higher":[163,211],"compared":[171],"with":[172,210,215],"prostate.":[174],"CONCLUSION:":[175],"defines":[178],"baseline":[180],"not":[185],"affected":[186],"(significantly":[189],"lower":[190],"liver).":[194],"Higher":[195],"established":[198],"hypertrophy.":[203],"Only":[204],"concomitant":[205],"associated":[209],"comparison":[214],"non-neoplastic":[216],"liver.":[217]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}